Background: Prostate-specific membrane antigen (PSMA) is a cell surface enzyme that is
highly expressed in prostate cancer (PCa) and is currently being extensively explored as a …

Despite current risk stratification systems using traditional clinicopathologic factors, many
localized and locally advanced prostate cancers fail radical treatment (ie, radical …

Background Risk of prostate cancer-specific mortality (PCSM) is highly variable for men with
adverse pathologic features at radical prostatectomy (RP); a majority will die of other causes …

Abstract Introduction The 2019 Coffey‐Holden Prostate Cancer Academy (CHPCA)
Meeting,“Prostate Cancer Research: The Next Generation,” was held 20 to 23 June, 2019, in …

Prostate cancer (PCa) is the main cause of cancer-related mortality in males and the
diagnosis, treatment, and care of these patients places a great burden on healthcare …

Purpose Because of many unanswered questions regarding men's health, a literature
review was performed to better understand the role of testosterone and testosterone …

Introduction The 2018 Coffey‐Holden Prostate Cancer Academy (CHPCA) Meeting,“Tumor
Cell Heterogeneity and Resistance,” was held in Los Angeles, California from June 21 to 24 …

Abstract Introduction The 2023 Coffey‐Holden Prostate Cancer Academy (CHPCA) Meeting,
themed “Disrupting Prostate Cancer Research: Challenge Accepted,” was convened at the …

Abstract Introduction The 2022 Coffey− Holden Prostate Cancer Academy (CHPCA)
Meeting,“Exploring New Frontiers in Prostate Cancer Research,” was held from June 23 to …

Abstract Introduction The 2021 Coffey‐Holden Prostate Cancer Academy (CHPCA)
Meeting,“Prostate Cancer Research in the 21st Century,” was held virtually, from June 24 …